Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92103


To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease

Study summary:

A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease


INCLUSION - Health Status 1. Healthy volunteers must be in good health 2. Celiac Disease must be well controlled and in good health - Either male or non-lactating, non-pregnant females who are postmenopausal, sterile or using at least two acceptable and highly effective birth control methods. - Body Mass Index (BMI) of < 30 kg/m2, EXCLUSION - A positive urine test for alcohol or illegal drugs at screening. - The subject has received an experimental drug within 30 days of the present study. - History of substance abuse, within the last 5 years - Clinically significant abnormal lab values, as determined by the PI - Alcohol consumption of > 2 standard drinks equivalents per day12. Positive pregnancy test within 7 days prior to study drug administration. - history of any medically significant condition considered by the PI to adversely affect participation in the trial



Primary Contact:

Principal Investigator
Vijaya Pratha, MD
Clinical Applications Laboratory Inc.

Backup Contact:


Location Contact:

San Diego, California 92103
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.